AI-driven drug repurposing identifies new uses for existing drugs by analyzing:
- Molecular similarity
- Gene expression signatures
- Clinical trial data
- All of these
Answer: All of these
Machine learning integrates chemical, genomic, clinical data to predict drug-disease associations. Accelerates therapy discovery (e.g., baricitinib for COVID-19). CSIR-OSDD pioneered open-source repurposing platforms. [[CSIR, ICMR Reports]]